|
Eligible Participants: Physicians |
Available for Physicians: 12/31/2007 to 12/31/2008 |
Abstract: Human papilloma virus (HPV) has been shown to be a causative agent in the development of anogenital warts, intraepithelial neoplasia, and invasive cancers. A quadravalent HPV vaccine has been approved recently for use in young women ages 11 to 26 years with the intent of protecting against the most common subtypes of HPV implicated in anogential disease (types 6, 11, 16, 18). This symposium was held on Monday, October 15, 2007, at the American Society for Reproductive Medicine 2007 Annual Meeting in Washington, DC, to explore the recent information regarding the efficacy of the vaccine, as well as discuss controversies regarding who else should be vaccinated, whether vaccination should be mandated, and if there is a role for the vaccine in protecting against HPV related disease in other sites of the body. |
Target Audience: Physicians |
|
CME Accreditation: The American Society for Reproductive Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. |
Sponsorship: Sponsored by the American Society for Reproductive Medicine. Supported by an educational grant from Merck & Co., Inc |
|
|
Eligible Participants: Physicians, Nurse Practictioners |
Available for Physicians: 6/1/2006 to 6/30/2008 |
Available for Nurse Practitioners: 6/1/2006 to 6/30/2008 |
Abstract: Diabetic peripheral neuropathic pain (DPNP) is a tragic outcome for 11% of those with diabetic peripheral neuropathy, which affects half of all patients with diabetes mellitus. Before 2004,there were no formally approved treatments for DPNP, and now there are 2. Importantly, last year many pain specialists with an interest in DPNP convened for a 2-day advisory group meeting to evaluate the literature and develop the first set of DPNP-specific guidelines for its management. With the increasing problem of obesity in America and the tragedy of more people (children,adolescents, and adults) with diabetes mellitus, we must be prepared to respond to the pain complaints of our patients with diabetes. The trend numbers suggest that millions of people will need our help in the coming years.This supplement contains the most current recommendations and practical suggestions for the management of DPNP. It offers a template for the management of pain in patients with diabetes. Primary care providers are expected to manage DPNP, and these guidelines will do much to help you with your patients. |
Target Audience: Family physicians and other primary care practitioners. |
|
CME Accreditation: This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Wisconsin School of Medicine and Public Health and the American Society of Pain Educators. The University of Wisconsin School of Medicine and |
Sponsorship: Supported by an educational grant from Eli Lilly and Company. |
|
|
Eligible Participants: Physicians, Nurse Practictioners |
Available for Physicians: 3/1/2007 to 3/1/2009 |
Available for Nurse Practitioners: 3/1/2007 to 3/1/2009 |
Abstract: The diagnosis and management of chronic pelvic pain and endometriosis represents a challenge for clinicians and their patients. Laparoscopy does not fully reveal the extent of disease. Neither surgical nor medical treatments provide a cure for endometriosis. Efficacious treatment requires multifaceted short- and long-term interventions to manage symptoms and help patients enjoy a good quality of life. |
Target Audience: Obstetricians/gynecologists, family physicians, nurse practitioners, physician assistants, and other clinicians who focus on women’s health. |
|
CME Accreditation: The University of Cincinnati designates this educational activity for a maximum of 2.5 AMA PRA Category 1 credits.TM Physicians should only claim credit commensurate with the extent of their participation in the activity. This CME activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Cincinnati College of Medicine and Dowden Health Media. The University of Cincinnati College of Medicine is accredited by the ACCME to provide continuing medical education for physicians. |
Sponsorship: This CME activity is supported by an unrestricted educational grant from TAP Pharmaceuticals. |
|
|
Eligible Participants: Physicians |
Available for Physicians: 12/1/2006 to 11/30/2007 |
Abstract: Reproductive-age women have varying contraceptive needs. For many women, long-term reversible contraception, defined as IUDs and implants for the purpose of this article, represents an excellent choice. Several options are currently available: the copper T intrauterine device, the levonorgestrel-releasing intrauterine system, and the single-rod progestin-only implant. Health care providers need reliable information to counsel their patients effectively and work with them to make the most appropriate contraceptive selection. |
Target Audience: Obstetricians/gynecologists, nurse practitioners, and other advanced practice clinicians who focus on women’s health. |
|
CME Accreditation: This CE/CME activity is supported by an unrestricted educational grant from Berlex, Inc. |
Sponsorship: The University of Cincinnati designates this educational activity for a maximum of 1 AMA PRA Category 1 credits.TM Physicians should only claim credit commensurate with the extent of their participation in the activity. This CME activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Cincinnati College of Medicine and Dowden Health Media. The University of Cincinnati College of Medicine is accredited by the ACCME to provide continuing medical education for physicians. |
|
|
Eligible Participants: Physicians |
Available for Physicians: 10/1/2007 to 10/31/2008 |
Abstract: ABTSTACT |
Target Audience: Influenza |
|
CME Accreditation: CAHE |
Sponsorship: Convergent / CAHE |
|
|
Eligible Participants: Physicians, Nurse Practictioners |
Available for Physicians: 3/1/2007 to 3/1/2008 |
Available for Nurse Practitioners: 3/1/2007 to 3/1/2008 |
Abstract: Overactive bladder (OAB) is a significant health concern that afflicts over 33 million, primarily older, patients in the United States. Although nonpharmacologic therapy is useful in OAB, the most effective treatment combines behavioral therapy and pharmacologic treatment with anticholinergic agents. The use of some anticholinergic treatments, however, is associated with mild and severe side effects, and older patients are at increased risk for suffering from such side effects. To ensure that informed decisions are made and the highest quality of care is achieved, physicians who treat older patients with OAB must be aware of these risks and the relevant new data for the FDA-approved agents for OAB. |
Target Audience: This continuing medical education offering is intended for obstetricians and gynecologists and other health care professionals. |
|
CME Accreditation: Cerebrio is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. |
Sponsorship: Cerebrio has planned and implemented this activity in accordance with the Essential Areas and Policies of the ACCME.Cerebrio designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credits ™. Physicians should only claim credit commensurate with the extent of their participation in the activity. |
|
|
Eligible Participants: Physicians, Nurse Practictioners |
Available for Physicians: 2/1/2007 to 2/29/2008 |
Available for Nurse Practitioners: 2/1/2007 to 2/29/2008 |
Abstract: Results from an ASRM survey and recent randomized trials involving administration of estrogens to postmenopausal women have confused clinicians about when it is appropriate to provide estrogen to such individuals. This symposium will consider the evidence and the advisability of treating postmenopausal women with symptoms of estrogen deficiency. The symposium should be of interest to all clinicians who struggle with when and to whom to provide menopausal hormone therapy. |
Target Audience: Obstetricians/gynecologists, nurse practitioners, and other advanced practice clinicians who focus on women’s health. |
|
CME Accreditation: Supported by ASRM and educational grants from Wyeth Pharmaceuticals and Solvay Pharmaceuticals, Inc. |
Sponsorship: The American Society for Reproductive Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. |
|
|
Eligible Participants: Physicians |
Available for Physicians: 8/1/2004 to 7/31/2005 |
Abstract: Treating patients with bipolar depression is challenging. There is far less evidence supporting various treatment strategies for bipolar depression than there is for bipolar mania. Although guidelines for treating patients presenting with bipolar depression have been published, many unanswered questions remain about various acute and long-term pharmacologic therapies. |
Target Audience: Psychiatrists |
|
CME Accreditation: This continuing medical education activity is supported by an unrestricted educational grant from Eli Lilly and Co. |
Sponsorship: University of Cincinnati College of Medicine Office of Continuing Medical Education |
|
|
Eligible Participants: Physicians, Nurse Practictioners |
Available for Physicians: 5/1/2007 to 4/30/2008 |
Available for Nurse Practitioners: 5/1/2007 to 4/30/2008 |
Abstract: Testosterone levels decline in men with the normal course of aging. Below certain levels, a deficiency of testosterone is clinically significant and can affect sexual function as well as the function of numerous organ systems. This dialogue among 2 family physicians and an endocrinologist explores diagnostic and treatment options in clinical practice with a focus on newly released guidelines from the Endocrine Society. |
Target Audience: Family practice physicians, nurse practitioners, physician assistants, and other clinicians with an interest in men’s health. |
|
CME Accreditation: This CME/CE activity is supported by an unrestricted educational grant from Solvay Pharmaceuticals, Inc. |
Sponsorship: The University of Cincinnati designates this educational activity for a maximum of 2.0 AMA PRA Category 1 creditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity. This CME activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of the University of Cincinnati College of Medicine. The University of Cincinnati College of Medicine is accredited by the ACCME to provide continuing medical education for physicians. |
|
|
Eligible Participants: Physicians, Nurse Practictioners |
Available for Physicians: 2/1/2007 to 12/31/2008 |
Available for Nurse Practitioners: 2/1/2007 to 12/31/2008 |
Abstract: Progesterone plays important roles in a woman’s normal reproductive cycle. Exogenous progestogen administration often is used to treat secondary amenorrhea, manage luteal phase deficiency, prevent endometrial hyperplasia, ameliorate dysfunctional uterine bleeding, and treat endometriosis. For a woman who has a uterus and who experiences menopausal symptoms, progesterone opposes estrogen’s effects on the endometrium (e.g., progesterone reduces mitotic activity and exerts antiproliferative effects). Progestogens also are used in assisted reproductive technologies and in contraceptive agents and emergency contraceptive regimens. Clinicians have numerous options in selecting a progestogen for the individual patient. The specific properties of progesterone or synthetic progestins may result in differing side-effect profiles for individual patients. Route of administration also offers differing systemic or local effects that should be considered for some uses and specific patients. |
Target Audience: This activity has been designed to meet the educational needs of health professionals who care for women from adolescence to postmenopause. |
|
CME Accreditation: The American Society for Reproductive Medicine designates this educational activity for a maximum of 1.5 category 1 credit toward the AMA Physician’s Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity. |
Sponsorship: This educational activity was made possible by an unrestricted educational grant from Solvay Pharmaceuticals. |
|
